Suzhou Innovative Biomaterials & Pharmaceutics

Suzhou Innovative Biomaterials & Pharmaceutics (SIBP) is a clinical-stage biotechnology company specializing in the development of long-acting, sustained-release drug delivery systems. The company utilizes proprietary in-situ forming hydrogel and polymer-based technologies to improve the therapeutic profile of existing drugs, particularly in the fields of ophthalmology and pain management. Their lead programs focus on providing long-term relief for postoperative pain and chronic ocular diseases, aiming to reduce the frequency of administration and improve patient compliance. SIBP operates primarily out of the Suzhou Industrial Park, a major hub for biopharmaceutical innovation in China.